These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32825005)

  • 1. Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy.
    Eckburg A; Dein J; Berei J; Schrank Z; Puri N
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Cancer by Targeting Telomeres and Telomerase.
    Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
    Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
    Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models.
    Berardinelli F; Coluzzi E; Sgura A; Antoccia A
    Mutat Res Rev Mutat Res; 2017 Jul; 773():204-219. PubMed ID: 28927529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
    Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
    Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
    Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
    Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.
    Tarazón E; de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Sahuquillo Torralba A; Simarro J; Palanca Suela S; Botella Estrada R
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere and Telomerase Therapeutics in Cancer.
    Xu Y; Goldkorn A
    Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
    Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
    Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
    Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF
    J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA.
    Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W
    J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing telomerase in cancer therapeutics.
    Fakhoury J; Nimmo GA; Autexier C
    Anticancer Agents Med Chem; 2007 Jul; 7(4):475-83. PubMed ID: 17630922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
    Qi Z; Mi R
    Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.
    Chen L; Lü MH; Zhang D; Hao NB; Fan YH; Wu YY; Wang SM; Xie R; Fang DC; Zhang H; Hu CJ; Yang SM
    Cell Death Dis; 2014 Jan; 5(1):e1034. PubMed ID: 24481448
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.